More specifically, a recent single-nucleus RNA sequencing study revealed that dysregulated pericytic SMAD3 (a main downstream effector of TGF-β) signaling is responsible for BBB dysfunction in AD [92]. The gene discussed is TGFB1; the disease is Alzheimer disease.